Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Crystal Deal Toy with 3D Laser Etching

Crystal deal toy, featuring 3D laser etching, commemorating a private placement by Nordic Nanovector. The Norwegian life sciences firm develops drugs for the treatment of cancer.

(9LJW269)
1 Image

Medicinal Cannabis Deal Toy

Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.

(20ALJ334)
2 Images
Custom financial tombstone commemorating the ipo of New Zealand-based medicinal cannabis firm Rua Bioscience.

Lung-Themed Crystal Deal Toy

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.

(20ALJ110)
1 Image

Biotech Private Placement Corporate Tombstone

Crystal deal toy marking a private placement by Colorado-based pharmaceutical firm Aytu Bioscience.

(9AMF327)
2 Images
Side View of crystal deal tombstone commemorating a private placement by Aytu Bioscience. The commercial-stage pharmaceutical company is based in Englewood, Colorado.

DNA Strand-Inspired Licensing Commemorative

Lucite commemorative celebrating a development and commercialization agreement between Takeda and Arrowhead Pharmaceuticals.

(21ALJ357)
2 Images
Custom Lucite commemorating a development and commercialization agreement between Japanese drug maker Takeda and California-based Arrowhead Pharmaceuticals. The agreement centers on drugs that treat disease by using RNA to block gene expression.

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.

Biopharma Stock Offering Tombstone

Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)

3 Images
Side view of crystal financial tombstone celebrating a direct offering of stock by Salarius Pharmaceuticals. (22AJH070) Back view of DNA strand-inspired financial tombstone marking an offering by clinical-stage firm Salarius Pharmaceuticals. (22AJH070)